Your browser doesn't support javascript.
loading
Pharmacodynamic effect of bempedoic acid and statin combinations: predictions from a dose-response model.
Jadhav, Satyawan B; Crass, Ryan L; Chapel, Sunny; Kerschnitzki, Michael; Sasiela, William J; Emery, Maurice G; Amore, Benny M; Barrett, P Hugh R; Watts, Gerald F; Catapano, Alberico L.
Afiliación
  • Jadhav SB; Ann Arbor Pharmacometrics Group, 900 Victors Way #328, Ann Arbor, MI 48108, USA.
  • Crass RL; Ann Arbor Pharmacometrics Group, 900 Victors Way #328, Ann Arbor, MI 48108, USA.
  • Chapel S; Ann Arbor Pharmacometrics Group, 900 Victors Way #328, Ann Arbor, MI 48108, USA.
  • Kerschnitzki M; Daiichi Sankyo Europe GmbH, Zielstattstraße 48, 81379 Munich, Germany.
  • Sasiela WJ; Esperion Therapeutics, Inc., 3891 Ranchero Dr, Ann Arbor, MI 48108, USA.
  • Emery MG; Esperion Therapeutics, Inc., 3891 Ranchero Dr, Ann Arbor, MI 48108, USA.
  • Amore BM; Esperion Therapeutics, Inc., 3891 Ranchero Dr, Ann Arbor, MI 48108, USA.
  • Barrett PHR; Faculty of Medicine and Health, University of New England, Armidale, NSW 2351, Australia.
  • Watts GF; School of Medicine, University of Western Australia, Medical Research Foundation Building, Rear 50 Murray Street, Perth, WA 6001, Australia.
  • Catapano AL; Department of Pharmacological and Biomolecular Sciences, University of Milan and IRCCS Multimedica, Via Balzaretti 9, 20133 Milan, Italy.
Eur Heart J Cardiovasc Pharmacother ; 8(6): 578-586, 2022 Sep 03.
Article en En | MEDLINE | ID: mdl-34448822
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur Heart J Cardiovasc Pharmacother Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur Heart J Cardiovasc Pharmacother Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos